Personalized medicine: Factors influencing reimbursement
- 8 October 2009
- journal article
- Published by Elsevier in Health Policy
- Vol. 94 (2) , 91-100
- https://doi.org/10.1016/j.healthpol.2009.09.006
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The Scientific Foundation for Personal Genomics: Recommendations from a National Institutes of Health–Centers for Disease Control and Prevention Multidisciplinary WorkshopGenetics in Medicine, 2009
- Direct-to-Consumer Genetic Testing: Two Sides of the CoinThe Journal of Molecular Diagnostics, 2009
- Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan?Genetics in Medicine, 2009
- TrastuzumabPharmacoEconomics, 2008
- Pharmacoeconomic Evaluations of Pharmacogenetic and Genomic Screening ProgrammesPharmacoEconomics, 2008
- Randomized Trial of Genotype-Guided Versus Standard Warfarin Dosing in Patients Initiating Oral AnticoagulationCirculation, 2007
- American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast CancerJournal of Clinical Oncology, 2007
- Impact of a 21‐gene RT‐PCR assay on treatment decisions in early‐stage breast cancerCancer, 2007
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- Diagnosis, management, and treatment of hepatitis C†Hepatology, 2004